Using the American College of Radiology's TI-RADS can cut back on biopsies by more than 50%, according to a new comparative analysis published in Cureus.

The analysis examined 620 cancer imaging studies from the top 25 imaging-related journals to come up with publication-to-incidence and publication-to-mortality ratios. 

Ultrasound pinpointed 4.3% fewer prostate cancers in comparison to multiparametric MRI, according to new research published in Lancet Oncology.

 The platform was developed using a combination of four different AI methods, according to research presented at the 2022 Multidisciplinary Head and Neck Cancers Symposium.

Such considerations will be important as more patients receive vaccines for the first time or additional boosters, experts wrote in Academic Radiology.

Women with ATM, CHEK2 and PALB2 gene mutations would benefit from beginning MRI screenings earlier than previously recommended, experts reported in JAMA Oncology.

The team originally planned to enroll 300 men in the study, but the decisive results seen among the first 100 patients prompted them to cut enrollment in half.

Concerningly, the number of patients diagnosed with stage 4 disease increased from 1.9% in 2019 to 6.2% in 2020, experts reported in JAMA Network Open.